Risk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With Cancer
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-06-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S246802492401547X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850127470520434688 |
|---|---|
| author | Paul E. Hanna Rajesh K. Anumolu Shveta S. Motwani Kevin L. Chen Nurit Katz-Agranov Olivia Green-Lingren Osman A. Yilmam Kenar D. Jhaveri Abhijat Kitchlu Jaya Kala Meghan E. Sise Shruti Gupta |
| author_facet | Paul E. Hanna Rajesh K. Anumolu Shveta S. Motwani Kevin L. Chen Nurit Katz-Agranov Olivia Green-Lingren Osman A. Yilmam Kenar D. Jhaveri Abhijat Kitchlu Jaya Kala Meghan E. Sise Shruti Gupta |
| author_sort | Paul E. Hanna |
| collection | DOAJ |
| format | Article |
| id | doaj-art-a8bfa169bd184ac3b9f5d662ea31a6e8 |
| institution | OA Journals |
| issn | 2468-0249 |
| language | English |
| publishDate | 2024-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney International Reports |
| spelling | doaj-art-a8bfa169bd184ac3b9f5d662ea31a6e82025-08-20T02:33:39ZengElsevierKidney International Reports2468-02492024-06-01961897190210.1016/j.ekir.2024.03.005Risk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With CancerPaul E. Hanna0Rajesh K. Anumolu1Shveta S. Motwani2Kevin L. Chen3Nurit Katz-Agranov4Olivia Green-Lingren5Osman A. Yilmam6Kenar D. Jhaveri7Abhijat Kitchlu8Jaya Kala9Meghan E. Sise10Shruti Gupta11Division of Nephrology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USADivision of Renal Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USALahey Hospital and Medical Center, Burlington, Massachusetts, USADepartment of Biostatistics, Harvard TH Chan School of Public Health, Boston, Massachusetts, USADepartment of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USADivision of Renal Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USADivision of Renal Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USADivision of Kidney Diseases and Hypertension, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USADivision of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, CanadaDivision of Renal Diseases and Hypertension, Department of Internal Medicine, University of Texas Health Science Center at Houston-McGovern Medical School, Texas, USADepartment of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USADivision of Renal Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA; Adult Survivorship Program, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Correspondence: Shruti Gupta, Division of Renal Medicine, Brigham and Women’s Hospital, 75 Francis St., MRB-4, Boston, Massachusetts 02115, USA.http://www.sciencedirect.com/science/article/pii/S246802492401547X |
| spellingShingle | Paul E. Hanna Rajesh K. Anumolu Shveta S. Motwani Kevin L. Chen Nurit Katz-Agranov Olivia Green-Lingren Osman A. Yilmam Kenar D. Jhaveri Abhijat Kitchlu Jaya Kala Meghan E. Sise Shruti Gupta Risk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With Cancer Kidney International Reports |
| title | Risk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With Cancer |
| title_full | Risk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With Cancer |
| title_fullStr | Risk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With Cancer |
| title_full_unstemmed | Risk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With Cancer |
| title_short | Risk Factors for Severe Hypertension and Proteinuria After Treatment With Vascular Endothelial Growth Factor Signaling Pathway Inhibitors Among Patients With Cancer |
| title_sort | risk factors for severe hypertension and proteinuria after treatment with vascular endothelial growth factor signaling pathway inhibitors among patients with cancer |
| url | http://www.sciencedirect.com/science/article/pii/S246802492401547X |
| work_keys_str_mv | AT paulehanna riskfactorsforseverehypertensionandproteinuriaaftertreatmentwithvascularendothelialgrowthfactorsignalingpathwayinhibitorsamongpatientswithcancer AT rajeshkanumolu riskfactorsforseverehypertensionandproteinuriaaftertreatmentwithvascularendothelialgrowthfactorsignalingpathwayinhibitorsamongpatientswithcancer AT shvetasmotwani riskfactorsforseverehypertensionandproteinuriaaftertreatmentwithvascularendothelialgrowthfactorsignalingpathwayinhibitorsamongpatientswithcancer AT kevinlchen riskfactorsforseverehypertensionandproteinuriaaftertreatmentwithvascularendothelialgrowthfactorsignalingpathwayinhibitorsamongpatientswithcancer AT nuritkatzagranov riskfactorsforseverehypertensionandproteinuriaaftertreatmentwithvascularendothelialgrowthfactorsignalingpathwayinhibitorsamongpatientswithcancer AT oliviagreenlingren riskfactorsforseverehypertensionandproteinuriaaftertreatmentwithvascularendothelialgrowthfactorsignalingpathwayinhibitorsamongpatientswithcancer AT osmanayilmam riskfactorsforseverehypertensionandproteinuriaaftertreatmentwithvascularendothelialgrowthfactorsignalingpathwayinhibitorsamongpatientswithcancer AT kenardjhaveri riskfactorsforseverehypertensionandproteinuriaaftertreatmentwithvascularendothelialgrowthfactorsignalingpathwayinhibitorsamongpatientswithcancer AT abhijatkitchlu riskfactorsforseverehypertensionandproteinuriaaftertreatmentwithvascularendothelialgrowthfactorsignalingpathwayinhibitorsamongpatientswithcancer AT jayakala riskfactorsforseverehypertensionandproteinuriaaftertreatmentwithvascularendothelialgrowthfactorsignalingpathwayinhibitorsamongpatientswithcancer AT meghanesise riskfactorsforseverehypertensionandproteinuriaaftertreatmentwithvascularendothelialgrowthfactorsignalingpathwayinhibitorsamongpatientswithcancer AT shrutigupta riskfactorsforseverehypertensionandproteinuriaaftertreatmentwithvascularendothelialgrowthfactorsignalingpathwayinhibitorsamongpatientswithcancer |